|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
Biogen-Idec as a combined company is a good, solid operating company. They have slowing sales however and, aside from Antegren (50% owned by Elan) not much of a pipeline.
Will be interesting to see how the supposed synergies from merger between Biogen and Idec play out.
Anyone have any ideas about this company?
|© 2022 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|